Lucid Diagnostics Inc.
LUCD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 104,027.3% | 40.5% | -30.8% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -40.1% | -53.5% | -87.3% | -79.2% |
| EBITDA | -$10 | -$0 | -$0 | -$0 |
| % Margin | -822% | -362.1% | -3,222% | -945% |
| Net Income | -$10 | -$0 | -$0 | -$0 |
| % Margin | -858.5% | -381.7% | -3,249.8% | -964.2% |
| EPS Diluted | -0.1 | -0.08 | -0.52 | -0.2 |
| % Growth | -25.5% | 84.7% | -160% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |